Although beta-arrestin-1 levels were comparable in ADC and SCC samples, beta-arrestin-1 concentrations were significantly higher in plasma from lung cancer patients when compared to healthy donors (Fig. 4a). This evidence concerns the gene ARRB1 and lung carcinoma.